Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.235
+0.015 (1.23%)
Aug 12, 2026, 12:42 PM EDT - Market open
Biofrontera Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.09 | -10.54 | -17.76 | -20.13 | -0.64 | -37.71 |
Depreciation & Amortization | 0.69 | 0.87 | 1.15 | 1.06 | 1.17 | 0.54 |
Stock-Based Compensation | 1.05 | 0.95 | 1.02 | 1.05 | 1.85 | 0.13 |
Other Adjustments | 0.35 | -1.16 | -0.89 | -2.48 | -21.37 | 11.83 |
Change in Receivables | 0.18 | -1.91 | -0.31 | 4.93 | 4.92 | -12 |
Changes in Inventories | 1.63 | 1.45 | 4.23 | -3.75 | -2.81 | 2.59 |
Changes in Accounts Payable | -1 | -0.54 | -1.81 | 6.42 | 0.91 | -0.77 |
Changes in Accrued Expenses | 0.87 | 0.61 | -0.23 | -6.35 | -3.61 | 12.48 |
Changes in Other Operating Activities | -1.46 | -3.1 | 4.33 | -5.64 | 3.37 | -3.81 |
Operating Cash Flow | -9.31 | -13.36 | -10.27 | -24.9 | -16.2 | -26.72 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | -0 | -0.01 | -0.01 | -0.04 | -0.01 |
Sale of Property, Plant & Equipment | - | 3 | - | - | - | - |
Purchases of Intangible Assets | - | - | -0.05 | - | - | - |
Purchases of Investments | - | - | - | - | -5.12 | - |
Proceeds from Sale of Investments | - | - | 0.06 | 0.62 | - | - |
Investing Cash Flow | 3 | 3 | -0 | 0.62 | -5.16 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | 3.8 | - | - |
Short-Term Debt Repaid | - | - | -4.32 | -21.34 | - | - |
Net Short-Term Debt Issued (Repaid) | - | - | -4.32 | -17.54 | - | - |
Long-Term Debt Issued | - | - | 4.05 | 21.45 | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | 4.05 | 21.45 | - | - |
Issuance of Common Stock | - | - | - | 4.51 | 14.02 | 43.19 |
Net Common Stock Issued (Repurchased) | - | - | - | 4.51 | 14.02 | 43.19 |
Issuance of Preferred Stock | - | 10.85 | 15.1 | - | - | - |
Net Preferred Stock Issued (Repurchased) | - | 10.85 | 15.1 | - | - | - |
Financing Cash Flow | - | 10.85 | 14.84 | 8.41 | 14.02 | 43.19 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 1.56 | 0.49 | 4.56 | -15.87 | -7.33 | 16.47 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.32 | -13.36 | -10.28 | -24.9 | -16.24 | -26.73 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -21.57% | -32.04% | -27.54% | -73.08% | -56.63% | -110.90% |
Free Cash Flow Per Share | -0.86 | -1.31 | -1.86 | -16.10 | -15.36 | -60.68 |
Levered Free Cash Flow | -16 | -11.25 | -10.36 | -24.5 | -1.64 | -26.69 |
Unlevered Free Cash Flow | -10.41 | -12.09 | -9.57 | -30.96 | -20.56 | -14.22 |